IMCB PJSC Logo

IMCB PJSC

Personal biobank preserving umbilical cord stem cells for families' future therapeutic use.

GEMA | MOEX

Overview

Corporate Details

ISIN(s):
RU000A100GC7
LEI:
Country:
Russian Federation
Address:
Gubkina St. House 3, 11933 Moscow
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

IMCB PJSC is a biotechnology company and a leading personal stem cell biobank, operating under the Gemabank brand. The company specializes in the processing and long-term cryopreservation of hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue. These services provide families with a personalized biological resource for potential use in cell therapy to treat a wide range of hematological, immune, and genetic disorders. Established in 2003, the company manages tens of thousands of client biomaterial samples and has a documented history of successfully providing them for clinical applications. IMCB is also engaged in research and development of innovative gene therapy and biopharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IMCB PJSC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMCB PJSC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMCB PJSC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden
RESP
REVELATION BIOSCIENCES, INC. Logo
Develops therapies that reprogram the innate immune system to reduce inflammation-related damage.
United States of America
REVB
REVIVA PHARMACEUTICALS HOLDINGS, INC. Logo
Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.
United States of America
RVPH
Revolution Medicines, Inc. Logo
A clinical-stage oncology company developing targeted therapies for RAS-addicted cancers.
United States of America
RVMD
ROKIT HEALTHCARE Inc. Logo
Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.
South Korea
376900
ROQUEFORT THERAPEUTICS PLC Logo
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom
ROQ
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland
RVU
Salarius Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.
United States of America
SLRX
SaltX Technology Holding B Logo
Develops electric calcination tech to decarbonize heavy industries like cement and capture CO2.
Sweden
SALT

Talk to a Data Expert

Have a question? We'll get back to you promptly.